Qinglin Li

4.0k total citations · 1 hit paper
86 papers, 3.3k citations indexed

About

Qinglin Li is a scholar working on Molecular Biology, Cancer Research and Plant Science. According to data from OpenAlex, Qinglin Li has authored 86 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 20 papers in Cancer Research and 14 papers in Plant Science. Recurrent topics in Qinglin Li's work include Cancer-related molecular mechanisms research (16 papers), Natural Compound Pharmacology Studies (8 papers) and Natural product bioactivities and synthesis (7 papers). Qinglin Li is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), Natural Compound Pharmacology Studies (8 papers) and Natural product bioactivities and synthesis (7 papers). Qinglin Li collaborates with scholars based in China, United States and Macao. Qinglin Li's co-authors include Xuncui Wang, Guoqi Zhu, Gabriel Eades, Yuan Yao, Yongshu Zhang, Esteban A. Roberts, Chihiro Akazawa, Chengyu Liang, Vojo Deretić and Kyung‐Soo Inn and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Qinglin Li

79 papers receiving 3.2k citations

Hit Papers

Beclin1-binding UVRAG targets the class C Vps complex to ... 2008 2026 2014 2020 2008 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking
    2008 626 citations Qinglin Li et al. profile →

Peers

Qinglin Li
Yao Shen China
Lijuan Gu China
Do‐Hee Kim South Korea
Chao Guo China
Hong‐Seob So South Korea
José L. Mauriz Spain
Qian Yang China
Consuelo Amantini Italy
Yuan‐Soon Ho Taiwan
Lei Gao China
Yao Shen China
Qinglin Li
Citations per year, relative to Qinglin Li Qinglin Li (= 1×) peers Yao Shen

Countries citing papers authored by Qinglin Li

Since Specialization
Citations

This map shows the geographic impact of Qinglin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglin Li more than expected).

Fields of papers citing papers by Qinglin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglin Li. The network helps show where Qinglin Li may publish in the future.

Co-authorship network of co-authors of Qinglin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglin Li. A scholar is included among the top collaborators of Qinglin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglin Li. Qinglin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Shujun, Lu Chen, Ying Wu, et al.. (2025). Cinobufagin inhibits hepatocellular carcinoma EMT-like stemness via VEGF/VEGFR2 autocrine signaling. Discover Oncology. 16(1). 930–930. 1 indexed citations
3.
Xu, Jiajie, Yuling Luo, Chenyue Zhan, et al.. (2025). Selection of Aptamers Targeting Different Epitopes of Recombinant Thyroid-Stimulating Hormone Receptor Protein. Analytical Chemistry. 97(27). 14565–14573.
4.
Guo, Xiao-Peng, Qinglin Li, Bo Zhang, et al.. (2025). Differences between second- and third-generation sequencing in capturing microbial community dynamics during Nongxiangxing Daqu storage. International Journal of Food Microbiology. 445. 111501–111501.
5.
Chen, Min, Jiaming Tian, Meng Wang, et al.. (2025). Gastrodin inhibits hexokinase-2 mediated glycolysis to rescue rotenone-damaged PC12 cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(12). 17161–17171.
6.
He, Feng, et al.. (2024). Advancements in research on the carbon dots nanomaterials in immune modulate and immunotherapy. Chemical Engineering Journal. 502. 157991–157991. 2 indexed citations
7.
Yang, Yuting, Chun Liu, Hui Cheng, et al.. (2024). Arenobufagin regulates the p62-Keap1-Nrf2 pathway to induce autophagy-dependent ferroptosis in HepG2 cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(7). 4895–4909. 9 indexed citations
8.
Wang, Meng, Yueyue Li, Shanshan Li, et al.. (2023). Cinobufacini injection delays hepatocellular carcinoma progression by regulating lipid metabolism via SREBP1 signaling pathway and affecting macrophage polarization. Journal of Ethnopharmacology. 321. 117472–117472. 10 indexed citations
9.
Song, Gang, Hui Cheng, Yu Cao, et al.. (2023). Smart anti-vascular nanoagent induces positive feedback loop for self-augmented tumor accumulation. Journal of Controlled Release. 356. 595–609. 5 indexed citations
10.
Li, Qinglin, et al.. (2023). Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients. Frontiers in Pharmacology. 14. 1124262–1124262. 6 indexed citations
11.
Cheng, Hui, et al.. (2023). Mechanism of Paris polyphylla saponin II inducing autophagic to inhibit angiogenesis of cervical cancer. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(5). 3179–3194. 4 indexed citations
12.
Wang, Meng, Hui Cheng, Huan Wu, et al.. (2022). Gambogenic acid antagonizes the expression and effects of long non-coding RNA NEAT1 and triggers autophagy and ferroptosis in melanoma. Biomedicine & Pharmacotherapy. 154. 113636–113636. 36 indexed citations
13.
Wu, Huan, Hong Wu, Rong Wang, et al.. (2019). Metabolites from Bufo gargarizans (Cantor, 1842): A review of traditional uses, pharmacological activity, toxicity and quality control. Journal of Ethnopharmacology. 246. 112178–112178. 69 indexed citations
14.
15.
Eades, Gabriel, Benjamin Wolfson, Yongshu Zhang, et al.. (2014). lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6. Molecular Cancer Research. 13(2). 330–338. 208 indexed citations
16.
Li, Qinglin. (2013). Gastrodin Protects PC12 Cells from Glutamate Toxicity by Down-regulating ERK1/2 and p38 Pathways. 1 indexed citations
17.
Li, Qinglin. (2011). Gambogenic acid induced apoptosis in human nasopharyngeal carcinoma CNE-1 cells and effect of p-p38 and p-ERK1/2 protein. Zhongguo yaolixue tongbao. 1 indexed citations
18.
Yan, Fenggen, Mei Wang, Jiaming Li, et al.. (2011). Gambogenic acid induced mitochondrial-dependent apoptosis and referred to Phospho-Erk1/2 and Phospho-p38 MAPK in human hepatoma HepG2 cells. Environmental Toxicology and Pharmacology. 33(2). 181–190. 68 indexed citations
19.
Li, Qinglin. (2008). Antitumor effects of neogambogic acid both in vivo and in vitro. Zhongcaoyao. 3 indexed citations
20.
Zhu, Guoqi, Mei Wang, Hui Cheng, et al.. (2008). Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP+-elicited apoptosis. Neuroscience Research. 63(1). 52–58. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao Shen Breakdown of academic impact, for papers by Lijuan Gu Breakdown of academic impact, for papers by Do‐Hee Kim Breakdown of academic impact, for papers by Chao Guo Breakdown of academic impact, for papers by Hong‐Seob So Breakdown of academic impact, for papers by José L. Mauriz Breakdown of academic impact, for papers by Qian Yang Breakdown of academic impact, for papers by Consuelo Amantini Breakdown of academic impact, for papers by Yuan‐Soon Ho Breakdown of academic impact, for papers by Lei Gao
Rankless by CCL
2026